Anti-inflammatory potential of Penicillium brefeldianum endophytic fungus supported with phytochemical profiling

Asmaa Saleh1, Walaa A Negm2, Thanaa A El-Masry3

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, 84428, Saudi Arabia.

Insights

The endophytic fungus Penicillium brefeldianum exhibits significant anti-inflammatory effects, reducing edema and inflammatory markers in a rat model. This natural compound shows promise for treating inflammation.

Area of Science:

  • Pharmacology
  • Mycology
  • Immunology

Background:

  • Acute inflammation involves pro-inflammatory cytokines, enzymes, and oxidative stress.
  • Natural products are explored for anti-inflammatory properties.

Purpose of the Study:

  • To investigate the anti-inflammatory potential of the endophytic fungus Penicillium brefeldianum.
  • To evaluate its effects on carrageenan-induced inflammation in rats.

Main Methods:

  • Isolation and identification of Penicillium brefeldianum using 18S rRNA gene sequencing.
  • Phytochemical profiling via LC-ESI-MS/MS.
  • Carrageenan-induced paw edema model in rats.
  • Histopathological, immunohistochemical, biochemical, and qRT-PCR analyses.

Main Results:

  • Significant reduction in paw edema and inflammatory cell infiltration in treated rats.
  • Decreased expression of cyclooxygenase-2 (COX-2) and tumor necrosis factor-alpha (TNF-α).
  • Reduced levels of prostaglandin E2 (PGE2), nitric oxide (NO), and malondialdehyde (MDA).
  • Downregulation of interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) gene expression.

Conclusions:

  • Penicillium brefeldianum possesses notable anti-inflammatory and antioxidant activities.
  • The fungus effectively mitigates key inflammatory mediators and pathways.
  • P. brefeldianum is a promising candidate for further research and development of anti-inflammatory therapies.

Related Concept Videos